Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 2371895, 12 pages
https://doi.org/10.1155/2017/2371895
Research Article

3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Enhance the Toxicity Induced by Copper in Rat Astrocyte Culture

1Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, S.S.A, 14269 México City, MEX, Mexico
2Biochemistry, Universidad Nacional Autónoma de México (UNAM), México City, MEX, Mexico
3Laboratorio de Neuroinmunología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, S.S.A, 14269 México City, MEX, Mexico

Correspondence should be addressed to Benjamín Pineda; moc.liamtoh@67oipneb and Verónica Pérez de la Cruz; xm.moc.oohay@depev

Received 24 March 2017; Accepted 11 June 2017; Published 31 July 2017

Academic Editor: Andrea Romani

Copyright © 2017 Daniela Ramírez-Ortega et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ferrer, “Metal poisoning,” Anales del Sistema Sanitario de Navarra, vol. 26, Supplement 1, pp. 141–153, 2003. View at Publisher · View at Google Scholar
  2. M. Valko, K. Jomova, C. J. Rhodes, K. Kuca, and K. Musílek, “Redox- and non-redox-metal-induced formation of free radicals and their role in human disease,” Archives of Toxicology, vol. 90, no. 1, pp. 1–37, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Valko, H. Morris, and M. T. Cronin, “Metals, toxicity and oxidative stress,” Current Medicinal Chemistry, vol. 12, no. 10, pp. 1161–1208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Lewinska-Preis, M. Jabłońska, M. J. Fabiańska, and A. Kita, “Bioelements and mineral matter in human livers from the highly industrialized region of the Upper Silesia Coal Basin (Poland),” Environmental Geochemistry and Health, vol. 33, no. 6, pp. 595–611, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. I. Bush, “Metals and neuroscience,” Current Opinion in Chemical Biology, vol. 4, no. 2, pp. 184–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Ferguson-Miller and G. T. Babcock, “Heme/copper terminal oxidases,” Chemical Reviews, vol. 96, no. 7, pp. 2889–2908, 1996. View at Publisher · View at Google Scholar
  7. D. M. Popovic, I. V. Leontyev, D. G. Beech, and A. A. Stuchebrukhov, “Similarity of cytochrome c oxidases in different organisms,” Proteins, vol. 78, no. 12, pp. 2691–2698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. P. Klinman, “The copper-enzyme family of dopamine beta-monooxygenase and peptidylglycine alpha-hydroxylating monooxygenase: resolving the chemical pathway for substrate hydroxylation,” The Journal of Biological Chemistry, vol. 281, no. 6, pp. 3013–3016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Perez-Aguilar, “Ceruloplasmine and iron metabolism: their implications in hemochromatosis, Wilson’s disease and aceruloplasminemia,” Revista Clínica Española, vol. 202, no. 12, pp. 649–651, 2002. View at Publisher · View at Google Scholar
  10. J. Healy and K. Tipton, “Ceruloplasmin and what it might do,” Journal Neural Transmission (Vienna), vol. 114, no. 6, pp. 777–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Pena, J. Lee, and D. J. Thiele, “A delicate balance: homeostatic control of copper uptake and distribution,” The Journal of Nutrition, vol. 129, no. 7, pp. 1251–1260, 1999. View at Google Scholar
  12. P. N. Lanken, “The challenge of medical decision making. Balancing patient autonomy and physician responsibility,” The American Review of Respiratory Disease, vol. 145, Part 1, no. 2, pp. 253-254, 1992. View at Publisher · View at Google Scholar
  13. J. R. Burdo, S. L. Menzies, I. A. Simpson et al., “Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat,” Journal of Neuroscience Research, vol. 66, no. 6, pp. 1198–1207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Eisses and J. H. Kaplan, “Molecular characterization of hCTR1, the human copper uptake protein,” The Journal of Biological Chemistry, vol. 277, no. 32, pp. 29162–29171, 2002. View at Publisher · View at Google Scholar
  15. S. A. Lee, O. V. Belyaeva, and N. Y. Kedishvili, “Biochemical characterization of human epidermal retinol dehydrogenase 2,” Chemico-Biological Interactions, vol. 178, no. 1–3, pp. 182–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Aschner, “Astrocyte metallothioneins (MTs) and their neuroprotective role,” Annals of the New York Academy of Sciences, vol. 825, pp. 334–347, 1997. View at Publisher · View at Google Scholar
  17. J. Hirrlinger and R. Dringen, “The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking,” Brain Research Reviews, vol. 63, no. 1-2, pp. 177–188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Kodama, C. Fujisawa, and W. Bhadhprasit, “Pathology, clinical features and treatments of congenital copper metabolic disorders—focus on neurologic aspects,” Brain Development, vol. 33, no. 3, pp. 243–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Gaggelli, H. Kozlowski, D. Valensin, and G. Valensin, “Copper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis),” Chemical Reviews, vol. 106, no. 6, pp. 1995–2044, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Greenough, J. Camakaris, and A. I. Bush, “Metal dyshomeostasis and oxidative stress in Alzheimer’s disease,” Neurochemistry International, vol. 62, no. 5, pp. 540–555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Meamar, H. Nikyar, L. Dehghani, K. Basiri, and M. R. Ghazvini, “Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson’s disease,” Advanced Biomedical Research, vol. 5, p. 31, 2016. View at Publisher · View at Google Scholar
  22. G. Allegri, G. Allegri, C. V. Costa, A. Bertazzo, M. Biasiolo, and E. Ragazzi, “Enzyme activities of tryptophan metabolism along the kynurenine pathway in various species of animals,” Farmaco, vol. 58, no. 9, pp. 829–836, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. C. A. Opitz and I. Heiland, “Dynamics of NAD-metabolism: everything but constant,” Biochemical Society Transactions, vol. 43, no. 6, pp. 1127–1132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Allegri, “Effects of two different loading doses of L-tryptophan on the urinary excretion of tryptophan metabolites in rats, mice and guinea pigs. Correlation with the enzyme activities,” The Italian Journal of Biochemistry, vol. 36, no. 3, pp. 194–203, 1987. View at Google Scholar
  25. G. Allegri, E. Ragazzi, A. Bertazzo, M. Biasiolo, and C. V. Costa, “Tryptophan metabolism in rabbits,” Advances in Experimental Medicine and Biology, vol. 527, pp. 473–479, 2003. View at Google Scholar
  26. J. Reyes Ocampo, R. Lugo Huitrón, D. González-Esquivel et al., “Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 646909, 22 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Schwarcz, “The kynurenine pathway of tryptophan degradation as a drug target,” Current Opinion in Pharmacology, vol. 4, no. 1, pp. 12–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. R. Guilarte and C. L. Eastman, “Is 3-hydroxykynurenine an endogenous neurotoxin in Huntington’s disease?” Journal of the Neurological Sciences, vol. 116, no. 2, pp. 227-228, 1993. View at Google Scholar
  29. S. J. Pearson and G. P. Reynolds, “Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington’s disease,” Neuroscience Letters, vol. 144, no. 1-2, pp. 199–201, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. C. L. Eastman and T. R. Guilarte, “Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line,” Brain Research, vol. 495, no. 2, pp. 225–231, 1989. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Nakagami, H. Saito, and H. Katsuki, “3-Hydroxykynurenine toxicity on the rat striatum in vivo,” Japanese Journal of Pharmacology, vol. 71, no. 2, pp. 183–186, 1996. View at Publisher · View at Google Scholar
  32. S. Okuda, N. Nishiyama, H. Saito, and H. Katsuki, “Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 22, pp. 12553–12558, 1996. View at Google Scholar
  33. S. Okuda, N. Nishiyama, H. Saito, and H. Katsuki, “3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity,” Journal of Neurochemistry, vol. 70, no. 1, pp. 299–307, 1998. View at Google Scholar
  34. L. E. Goldstein, M. C. Leopold, X. Huang et al., “3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction,” Biochemistry, vol. 39, no. 24, pp. 7266–7275, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Vazquez, J. A. Aquilina, J. F. Jamie, M. M. Sheil, and R. J. Truscott, “Novel protein modification by kynurenine in human lenses,” The Journal of Biological Chemistry, vol. 277, no. 7, pp. 4867–4873, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Leipnitz, G. Leipnitz, C. Schumacher et al., “In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain,” Neurochemistry International, vol. 50, no. 1, pp. 83–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Goshima, A. Wadano, and K. Miura, “3-Hydroxykynurenine as O2-. Scavenger in the blowfly, Aldrichina grahami,” Biochemical and Biophysical Research Communications, vol. 139, no. 2, pp. 666–672, 1986. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Backhaus, H. Rahman, S. Scheffler, H. Laatsch, and R. Hardeland, “NO scavenging by 3-hydroxyanthranilic acid and 3-hydroxykynurenine: N-nitrosation leads via oxadiazoles to o-quinone diazides,” Nitric Oxide, vol. 19, no. 3, pp. 237–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Reyes-Ocampo, D. Ramírez-Ortega, G. V. Cervantes et al., “Mitochondrial dysfunction related to cell damage induced by 3-hydroxykynurenine and 3-hydroxyanthranilic acid: non-dependent-effect of early reactive oxygen species production,” Neurotoxicology, vol. 50, pp. 81–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Quagliariello, F. Palmieri, A. Alifano, and S. Papa, “3-Hydroxyanthranilic acid-mediated respiration in the inhibited respiratory chain,” Biochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation, vol. 113, no. 3, pp. 482–489, 1966. View at Publisher · View at Google Scholar
  41. E. Quagliariello, S. Papa, C. Saccone, and A. Alifano, “Effect of 3-hydroxyanthranilic acid on the mitochondrial respiratory system,” The Biochemical Journal, vol. 91, no. 1, pp. 137–146, 1964. View at Publisher · View at Google Scholar
  42. N. Braidy, R. Grant, B. J. Brew, S. Adams, T. Jayasena, and G. J. Guillemin, “Effects of kynurenine pathway metabolites on intracellular NAD+ synthesis and cell death in human primary astrocytes and neurons,” International Journal of Tryptophan Research, vol. 2, pp. 61–69, 2009. View at Google Scholar
  43. D. Krause, H. S. Suh, L. Tarassishin et al., “The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1,” The American Journal of Pathology, vol. 179, no. 3, pp. 1360–1372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Riha, J. Karlíčková, T. Filipský, K. Macáková, R. Hrdina, and P. Mladěnka, “Novel method for rapid copper chelation assessment confirmed low affinity of D-penicillamine for copper in comparison with trientine and 8-hydroxyquinolines,” Journal of Inorganic Biochemistry, vol. 123, pp. 80–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. F. Collins, J. R. Prohaska, and M. D. Knutson, “Metabolic crossroads of iron and copper,” Nutrition Reviews, vol. 68, no. 3, pp. 133–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Yagi, H. Hayashi, T. Higuchi, N. Hishida, and N. Sakamoto, “Three stages of copper accumulation in hepatocellular lysosomes: X-ray microanalysis of copper-loaded golden hamsters,” International Journal of Experimental Pathology, vol. 73, no. 1, pp. 85–94, 1992. View at Google Scholar
  47. V. Pérez-De La Cruz, D. Elinos-Calderón, P. Carrillo-Mora et al., “Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition,” Neurochemistry International, vol. 56, no. 6-7, pp. 834–842, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. N. Herrera-Mundo, D. Silva-Adaya, P. D. Maldonado et al., “S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction,” Neuroscience Research, vol. 56, no. 1, pp. 39–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Lugo-Huitron, T. Blanco-Ayala, P. Ugalde-Muniz et al., “On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress,” Neurotoxicology and Teratology, vol. 33, no. 5, pp. 538–547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. D. R. Green and J. C. Reed, “Mitochondria and apoptosis,” Science, vol. 281, no. 5381, pp. 1309–1312, 1998. View at Publisher · View at Google Scholar
  51. S. Salvioli, A. Ardizzoni, C. Franceschi, and A. Cossarizza, “JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis,” FEBS Letters, vol. 411, no. 1, pp. 77–82, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Magana-Maldonado, K. Manoutcharian, N. Y. Hernández-Pedro et al., “Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 2, pp. 291–301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Sullivan, G. Robison, Y. Pushkar, J. K. Young, and K. F. Manaye, “Copper accumulation in rodent brain astrocytes: a species difference,” Journal of Trace Elements in Medicine and Biology, vol. 39, pp. 6–13, 2017. View at Publisher · View at Google Scholar
  54. S. Manoharan, G. J. Guillemin, R. S. Abiramasundari, M. M. Essa, M. Akbar, and M. D. Akbar, “The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8590578, 15 pages, 2016. View at Publisher · View at Google Scholar
  55. H. L. Hu, X. S. Ni, S. Duff-Canning, and X. P. Wang, “Oxidative damage of copper chloride overload to the cultured rat astrocytes,” American Journal of Translational Research, vol. 8, no. 2, pp. 1273–1280, 2016. View at Google Scholar
  56. F. Bulcke, P. Santofimia-Castaño, A. Gonzalez-Mateos, and R. Dringen, “Modulation of copper accumulation and copper-induced toxicity by antioxidants and copper chelators in cultured primary brain astrocytes,” Journal of Trace Elements in Medicine and Biology, vol. 32, pp. 168–176, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. P. V. Reddy, K. V. Rao, and M. D. Norenberg, “The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes,” Laboratory Investigation, vol. 88, no. 8, pp. 816–830, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Ferruzza, S. Ferruzza, Y. Sambuy et al., “Copper uptake and intracellular distribution in the human intestinal Caco-2 cell line,” Biometals, vol. 13, no. 2, pp. 179–185, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. A. V. Gyulkhandanyan, C. J. Feeney, and P. S. Pennefather, “Modulation of mitochondrial membrane potential and reactive oxygen species production by copper in astrocytes,” Journal of Neurochemistry, vol. 87, no. 2, pp. 448–460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. G. I. Giles, C. A. Collins, T. W. Stone, and C. Jacob, “Electrochemical and in vitro evaluation of the redox-properties of kynurenine species,” Biochemical and Biophysical Research Communications, vol. 300, no. 3, pp. 719–724, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Baran, K. Staniek, M. Bertignol-Spörr, M. Attam, C. Kronsteiner, and B. Kepplinger, “Effects of various kynurenine metabolites on respiratory parameters of rat brain, liver and heart mitochondria,” International Journal of Tryptophan Research, vol. 9, pp. 17–29, 2016. View at Publisher · View at Google Scholar
  62. S. Vazquez, B. Garner, M. M. Sheil, and R. J. Truscott, “Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions,” Free Radical Research, vol. 32, no. 1, pp. 11–23, 2000. View at Google Scholar
  63. I. Ascone, A. Longo, H. Dexpert, M. R. Ciriolo, G. Rotilio, and A. Desideri, “An X-ray absorption study of the reconstitution process of bovine Cu,Zn superoxide dismutase by Cu(I)-glutathione complex,” FEBS Letters, vol. 322, no. 2, pp. 165–167, 1993. View at Publisher · View at Google Scholar · View at Scopus
  64. M. R. Ciriolo, A. Desideri, M. Paci, and G. Rotilio, “Reconstitution of Cu,Zn-superoxide dismutase by the Cu(I).glutathione complex,” The Journal of Biological Chemistry, vol. 265, no. 19, pp. 11030–11034, 1990. View at Google Scholar
  65. A. M. Ferreira, A. D. Ferreira, M. R. Ciriolo, L. Marcocci, and G. Rotilio, “Copper(I) transfer into metallothionein mediated by glutathione,” The Biochemical Journal, vol. 292, Part 3, pp. 673–676, 1993. View at Publisher · View at Google Scholar
  66. R. Van Heyningen, “Fluorescent glucoside in the human lens,” Nature, vol. 230, no. 5293, pp. 393-394, 1971. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Garner, S. Vazquez, R. Griffith, R. A. Lindner, J. A. Carver, and R. J. Truscott, “Identification of glutathionyl-3-hydroxykynurenine glucoside as a novel fluorophore associated with aging of the human lens,” The Journal of Biological Chemistry, vol. 274, no. 30, pp. 20847–20854, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Garner, B. Garner, D. C. Shaw, R. A. Lindner, J. A. Carver, and R. J. Truscott, “Non-oxidative modification of lens crystallins by kynurenine: a novel post-translational protein modification with possible relevance to ageing and cataract,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1476, no. 2, pp. 265–278, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. S. M. Lee, Y. S. Lee, J. H. Choi et al., “Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion,” Immunology Letters, vol. 132, no. 1-2, pp. 53–60, 2010. View at Publisher · View at Google Scholar · View at Scopus